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To investigate the pathophysiological significance of infiltrating antitumour immune cells, we evaluated the quantity of immune cell
intratumoral infiltration in 110 surgically resected gallbladder specimens by immunohistochemistry. We examined 45 cases of
gallbladder cancer and 65 cases of benign gallbladder diseases for CD4
þ T cells, CD8
þ T cells, natural killer cells (NKCs), and
dendritic cells (DCs). High levels of CD4
þ T cell, CD8
þ T cell, NKC, and DC infiltration were recognised in 51.1% (23 out of 45),
37.8% (17 out of 45), 33.3% (15 out of 45), and 48.9% (22 out of 45) of cancer specimens, respectively. High numbers of infiltrating
CD4
þ and CD8
þ T cells correlated with decreasing tumour invasion, and high numbers of infiltrating DCs correlated with
decreasing lymph-node tumour metastasis. Furthermore, increased infiltration of CD4
þ and CD8
þ T cells and DCs exhibited a
significant correlation with prolonged survival. NKC infiltration, however, did not correlate with any of the clinicopathological factors
examined. Additionally, high levels of infiltration were not identified in specimens from benign diseases, consistent with the cancer-
specific activity of CD4
þ and CD8
þ T cells and DCs. In this study, we demonstrate that CD4
þ and CD8
þ tumour-infiltrating
lymphocyte and DCs, but not NKCs, are important factors in the accurate prognosis of survival after surgical removal of gallbladder
adenocarcinoma.
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The prognosis for patients with gallbladder cancer remains poor
despite improved diagnostic methods and surgical techniques. The
5-year survival rate after surgery is less than 15% (Donohue et al,
1990; Gall et al, 1991; Oertli et al, 1993; Cubertafond et al, 1994;
Ruckert et al, 1996). The prognostic factors for gallbladder cancer
are lymph-node metastases and the local extent of the primary
tumour, which significantly influence surgical course and deter-
mine the prognosis after surgery (Tsukada et al, 1997; Sugawara
et al, 1999). Recently, molecular biological studies have reported
that specific cancer-derived proteins are associated with progres-
sion and prognosis in gallbladder cancer (Hui et al, 2000; Shi et al,
2000; Kawamoto et al, 2001; Quan et al, 2001).
Both tumour-specific and nonspecific lymphocytes play an
important role in antitumour immune responses, through tumour
recognition and immunological elimination of local and metastatic
tumour cells (Boon et al, 1994; Brandle et al, 1996; Whiteside and
Herberman, 1995; Tanaka et al, 1997).
A single malignant cell may have multiple tumour-specific
antigens (Wortzel et al, 1983; Knuth et al, 1989; Van den Eynde
et al, 1989). Cytotoxic CD8
þ T cells recognise MHC class I
molecules bearing antigenic peptides derived from endogenously
synthesised proteins (Larsson et al, 2001). As the majority of
tumours express MHC class I, CD8
þ T cells can directly lyse
tumour cells and destroy large tumour masses in vivo (Wang,
2001). In contrast to CD8
þ T cells, CD4
þ T cells recognise
tumour-specific antigenic peptides on MHC class II molecules via
an exogenous processing pathway (Larsson et al, 2001). Cytokines,
such as IL-2 or IFN-gamma, released by CD4
þ T cells upon
antigenic stimulation are important for the antitumour effects of
activated CD4
þ T cells in vivo (Mumberg et al, 1999; Marzo et al,
2000; Beatty and Paterson, 2001). Activation of both T-cell subsets
requires the presentation of antigenic peptides on professional
antigen-presenting cells (APCs) (Larsson et al, 2001). Dendritic
cells (DCs), the most potent APCs, play a central role in
antitumour immunity by engulfing tumour antigens to facilitate
the stimulation of antigen-specific T cells (Lespagnard et al, 1999;
Almand et al, 2000). Natural killer cells (NKCs), comprising
approximately 15% of all circulating lymphocytes, are a compo-
nent of the innate immune system with the ability to lyse tumour
cells and to provide early sources of immunoregulatory cytokines
(Cooper et al, 2001).
Multiple immunohistochemical studies have described the
relationship between immune-cell infiltration and tumour pro-
gression or prognosis in several cancers (Naito et al, 1998;
Lespagnard et al, 1999; Ishigami et al, 2000a,b; Nakano et al, 2001;
Schumacher et al, 2001). These studies have formed the basis for
the practical application of immunotherapy (Malone et al, 2001;
Valone et al, 2001; Ying et al, 2001; Barnea et al, 2002; Dhodapkar
et al, 2002). The clinicopathological significance of infiltrating
antitumour immune cells within gallbladder adenocarcinomas,
however, has not been clarified. Received 2 December 2002; revised 4 July 2003; accepted 31 July 2003
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infiltration of CD4
þ T cells, CD8
þ T cells, NKCs, and DCs with
tumour progression to identify favourable prognostic factors for
patients with adenocarcinoma of the gallbladder.
MATERIALS AND METHODS
Patients
Between 1989 and 1999, we obtained samples from 110 gallblad-
ders resected in the Department of Surgical Oncology, Division of
Cancer Medicine at the Hokkaido University Graduate School of
Medicine and affiliated hospitals. In every case, informed consent
was obtained from the subject and guardian. In all, 45 cases were
diagnosed as primary gallbladder adenocarcinoma (17 males and
28 females with a mean age of 66.7 years). No distant metastases
were detected at preoperative examination. The clinical typing of
tumours was performed according to the guidelines of the TNM
Classification of Malignant Tumours (International Union Against
Cancer, 1997). Nine tumours were classified as Stage I, 15 as Stage
II, 5 as Stage III, and 16 as Stage IV.
Standard clinical treatment for advanced gallbladder cancer
comprised removal of the gallbladder, wedge resection of the liver,
resection of the extrahepatic bile duct, and resection of the
regional lymph nodes. If the primary tumour or metastatic lymph
nodes involve adjacent organs, including the head of the pancreas,
duodenum, or colon, additional extended surgery to remove the
affected area through pancreaticoduodenectomy, major hepatect-
omy, or colectomy was employed. Simple cholecystectomy was
performed for early gallbladder cancer.
Benign diseases of the gallbladder included 20 cases of
cholecystitis without anomalous pancreaticobiliary ductal junction
(APBDJ), 24 cases of cholecystitis with APBDJ, 14 cases of
adenomyomatosis, and seven adenomas. Among the seven gall-
bladder adenomas, six were diagnosed as tubular adenoma while
one was characterized as a papillary adenoma. No evidence of
intramucosal carcinoma was present in any of the adenoma cases.
All cases of benign disease were treated by simple cholecystectomy.
Tissue specimens were fixed in 10% formalin and embedded in
paraffin wax. Representative blocks including the greatest dimen-
sion of the tumour were selected; 4mm-thick serial sections were
examined by immunohistochemistry.
Immunohistochemistry
Immunohistochemical reactions were performed using the strep-
tavidin-biotin-peroxidase method. The mouse monoclonal pri-
mary antibodies used were anti-human CD4, anti-human CD8
(pre-diluted, Nichirei Corporation, Tokyo, Japan), anti-human
CD57 (Leu 7, Becton Dickinson Immunocytometry System, San
Jose, CA, USA) at a dilution of 1:5, and anti S-100 protein (DAKO,
Glostrup, Denmark) at a dilution of 1:2000. CD57 identifies cells
originating from the neural crest, including NKCs (Sangueza and
Requena, 1998; Ishigami et al, 2000a,b), while S-100 protein is an
adequate marker of DCs (Lespagnard et al, 1999; Ishigami et al,
2000a). As positive controls, the normal adenoid tissue, prostate
gland and nerve fibre were stained for CD4 and CD8, CD57, and S-
100 protein, respectively. Sections were deparaffinised in xylene,
washed in phosphate-buffered saline (PBS, pH 7.4), and rehydrated
through a graded series of ethanol solutions. For CD4 and CD8
immunohistochemistry, following treatment with sodium citrate
buffer (Ventana-Bio Tek Solutions, Tucson, AZ, USA), specimens
were subjected to autoclave heat for 20min, and to microwave heat
for 20min, respectively. Endogenous peroxidase activity was
blocked by a 10min incubation with 3% hydrogen peroxide
methanol. Following washing in PBS, specimens were saturated
with 10% normal goat serum (Histofine SAB-PO kit, Nichirei
Corporation, Tokyo, Japan) for 5min, then incubated at room
temperature for 30min with primary antibody. After washing in
PBS, a biotinylated goat anti-mouse immunoglobulin antibody
(Histofine SAB-PO kit, Nichirei Corporation, Tokyo, Japan) was
applied during a 60min incubation at room temperature.
Immunohistochemical reactions were visualised with freshly
prepared 3,30-diamino-benzidine tetrahydrochloride (Histofine
SAB-PO kit, Nichirei Corporation, Tokyo, Japan). Slides were
counterstained with haematoxylin and mounted on coverslips.
Immunostained sections were evaluated under a microscope
(Olympus, Japan).
Quantification methods
The degree of immune cell infiltration was observed in more than
10 independent high-power ( 200) microscopic fields (HPF) for
each tissue sample. The three areas with the most abundant
distribution were selected.
CD4
þ and CD8
þ T cells were quantified as described (Naito
et al, 1998), with the following modifications. An average of more
than 50 per three HPF accumulating CD4
þ or CD8
þ TILs were
designated as infiltration. Individual cases were classified into
high, low or no CD4
þ or CD8
þ TIL infiltration based on location
and quantitation. The high group possessed immunoreactive T
cells in the epithelial component of the tumour, either accumulat-
ing within the cancer cell nests and complexes or found
predominantly in the mesenchymal stroma surrounding the
epithelial component of the tumour. The low group exhibited
immunoreactive T cells sparse, evenly distributed CD4
þ or CD8
þ
TILs between the epithelial and stromal components and/or along
the invasive margin of the tumour. The negative group did not
demonstrate any immunoreactive T cells in either the epithelial
and stromal components or along the invasive margin of the
tumour.
Natural killer cells and DCs were quantified according to the
method of Ishigami et al (2000a). In intratumoral fields, 10 or
more NKCs per 10 HPF were defined as possessing high NKC
infiltration, while less than 10 NKCs per 10 HPF were designated as
low NKC infiltration. A total of 20 or more DCs per HPF were
defined as high DC infiltration; less than 20 DCs per HPF
characterised low DC infiltration.
In benign diseases, immunoreactive cells within and surround-
ing the epithelial lesion were quantitated.
The degree of immune cell infiltration for each section was
represented by the median of scores evaluated by three
investigators. All specimens were evaluated without any previous
knowledge of the patients’ clinical background.
Statistical analysis
The w
2 test and Fisher’s exact test were employed when
appropriate. The Kaplan–Meier method was used to estimate the
overall survival. Survival differences were analysed by the log-rank
test, based on the status of immune cell infiltration. Univariate
analyses of immune cell infiltration and clinicopathological
features were performed using the Cox proportional hazards
model. Probability (P) values of less than 0.05 were regarded
as significant in all the analyses. Statistical analyses were
performed using statistical software (StatView J version 5.0;
Abacus Concepts Inc.).
RESULTS
Immunohistochemistry for immune cells
CD4
þ T cells were distributed mainly along the invasive
margin and in the cancer stroma. Of the total cancer cases,
51.1% (23 out of 45) were recognised as possessing high CD4
þ
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cancer cell nests (Figure 1A). CD8
þ T cells were also distributed
along the invasive margin and within the cancer stroma; 37.8%
(17 out of 45) possessed high CD8
þ T cell infiltration. In 10
cases, TILs were found within cancer cell nests (Figure 1B).
NKC infiltration varied from 0 to 7.3/HPF (average 1.2); 33.3%
of the total cases (15 out of 45) contained high NKC
infiltration. NKCs diffusely infiltrated the cancerous lesions
(Figure 1C). DC infiltration varied from 0 to 88/HPF (average
22.8), with 48.9% (22 out of 45) exhibiting high DC infiltration.
DCs were also observed diffusely throughout the lesions
(Figure 1D).
In cases of benign disease, little or no infiltration of any kind of
immune cells were observed (Figure 2).
Figure 1 Representative photomicrographs of immunohistochemical staining of immune cells within gallbladder cancer (scale bar, 40mm). (A) high
CD4
þ TILs; (B) high CD8
þ TILs; (C) high NKC infiltration; (D) high DC infiltration.
Figure 2 Representative photomicrographs of immunohistochemical staining of immune cells in adenomas of the gallbladder (scale bar, 40mm). (A)
adenoma stained for CD4; (B) adenoma stained for CD8; (C) adenoma stained for CD57; (D) adenoma stained for S-100 protein.
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significance
For the 45 patients with gallbladder cancer, we acquired
pathological data on TNM classification, differentiation, vessel
involvement, lymphatic involvement, perineural involvement, and
stage grouping. Follow-up and clinical data were also obtained for
all 45 patients. All cases of cancer evaluated in this study were
diagnosed as adenocarcinomas. The details of high-level infiltra-
tion of immune cells and pT, pN, G categories, and p-stage
grouping are indicated in Table 1. No cases of pM1 were identified.
The quantity of infiltrating CD4
þ TILs correlated with vessel
involvement, pT category, and stage grouping. The number of
intratumoral CD8
þ TILs correlated with age, vessel involvement,
perineural involvement, and pT category. DC infiltration also
correlated with pN category and stage grouping. NKC infiltration
did not demonstrate any significant correlations with any of the
examined clinicopathological factors (Tables 2, 3). Additionally,
the strong correlation between TILs and depth of invasion is
suggested in Table 1.
Relationship among immunological factors
The number of infiltrating CD4
þ cells also correlated with CD8
þ
TILs and DC infiltration (Table 4). There was no correlation,
however, between the numbers of CD8
þ TILs and DC infiltration
(P¼0.2989). NKC infiltration did not correlate with any other
immunological factors.
Table 1 High level infiltration of immune cells and histopathological findings in gallbladder cancer
Variables High CD4
+ TILs (%) High CD8
+ TILs (%) High NKC infiltration (%) High DC infiltration (%)
Depth of invasion
pT1 (n¼9) 5 (55.6) 5 (55.6) 3 (33.3) 6 (66.7)
pT2 (n¼22) 16 (72.7) 11 (50.0) 7 (31.8) 12 (54.5)
pT3 (n¼9) 1 (11.1) 1 (11.1) 4 (44.4) 2 (22.2)
pT4 (n¼5) 1 (20.0) 0 (0.0) 1 (20.0) 2 (40.0)
Lymph node metastasis
pN0 (n¼27) 12 (44.4) 16 (59.3) 10 (37.0) 17 (63.0)
pN1 (n¼6) 1 (16.7) 1 (16.7) 2 (33.3) 1 (16.7)
pN2 (n¼12) 4 (33.3) 6 (50.0) 3 (25.0) 4 (33.3)
Histopathological grading
G1 (n¼27) 12 (44.4) 17 (63.0) 9 (33.3) 16 (59.3)
G2 (n¼15) 3 (33.3) 4 (26.7) 6 (40.0) 4 (26.7)
G3 (n¼3) 2 (66.7) 2 (66.7) 0 (0.0) 2 (66.7)
P-stage grouping
I( n¼9) 5 (55.6) 5 (55.6) 3 (33.3) 6 (66.7)
II (n¼15) 11 (73.3) 7 (46.7) 6 (40.0) 10 (66.7)
III (n¼5) 1 (20.0) 1 (20.0) 2 (40.0) 1 (20.0)
IV (n¼16) 6 (37.5) 4 (25.0) 4 (25.0) 5 (31.3)
TILs¼tumour-infiltrating lymphocytes; NKC¼natural killer cell; DC¼dendritic cell.
Table 2 Correlation between immune cells and clinicopathological features
CD4
+ TILs CD8
+TILs NKCs DCs
Variables Total (n¼45) Low/high P
a Low/high P
a Low/high P
a Low/high P
a
Age (years)
o69 22 14/8 0.0529 17/5 0.0417 16/6 0.3990 13/9 0.2949
X69 23 8/15 11/12 14/9 10/13
Sex
Male 17 7/10 0.4200 10/7 0.7141 14/3 0.0820 8/9 0.6718
Female 28 15/13 18/10 16/12 15/13
Vessel involvement
  28 10/18 0.0233 14/14 0.0300 19/9 0.8279 12/16 0.1552
+ 17 12/5 14/3 11/6 11/6
Lymphatic involvement
  23 13/10 0.4578 12/11 0.1552 15/8 0.8330 12/11 0.8841
+ 22 12/10 16/6 15/7 11/11
Perineural involvement
  28 11/17 0.0981 14/14 0.0300 19/9 0.8279 12/16 0.1552
+ 17 11/6 14/3 11/6 11/6
aw
2 test. TILs¼tumour-infiltrating lymphocytes; NKCs¼natural killer cells; DCs¼dendritic cells. The underlined numbers¼significant.
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Using Kaplan–Meier actuarial analysis, the overall survival for
patients possessing high numbers of CD4
þ TILs, CD8
þ TILs, and
infiltrating DCs was significantly better than in exhibiting low
infiltration (Figure 3A, B, and D). NKC infiltration did not
correlate with survival (Figure 3C).
The numbers of CD4
þ and CD8
þ TILs, age, pT category,
pN category, G category, vessel involvement, lymphatic involve-
ment, and perineural involvement were identified by Cox
univariate regression analysis as significant prognostic predictors
(Table 5).
DISCUSSION
In gallbladder cancer, lymph-node metastases and depth of
invasion of the primary tumour significantly affect patient
outcome after surgery (Tsukada et al, 1997). Strong correlations
between these pathological factors and the numbers of infiltrating
immune cells suggest that the antitumour immune response may
influence the prognosis of patients with gallbladder cancer in this
Table 3 Correlation between immune cells and TNM classification, tumour differentiation, and stage grouping
CD4
+TILS CD8
+TILs NKCs DCs
Variables Total (n¼45) Low/high P
a Low/high P
a Low/high P
a Low/high P
a
pT
b
1, 2 31 10/21 0.0009 16/15 0.0044 21/10 40.9999* 13/18 0.0669
3, 4 14 12/2 13/1 9/5 10/4
pN
c
0 27 11/16 0.1805 15/12 0.2586 17/10 0.5186 10/17 0.0207
1, 2 18 11/7 13/5 13/5 13/5
pM
d
0 45 22/23 – 28/17 – 30/15 – 23/22 –
1 0 0/0 0/0 0/0 0/0
G
e
1 27 10/17 0.0514 15/12 0.2586 18/9 40.9999 11/16 0.0883
2, 3 18 12/6 13/5 12/6 12/6
P-stage
I, II 24 8/16 0.0256 12/12 0.0706 15/9 0.5262 8/16 0.0108
III, IV 21 14/7 16/5 15/6 15/6
aw
2 test except for *Fisher’s exact test.
bdepth of invasion;
clymph node metastasis;
ddistant metastasis;
ehistopathological grading. TILs¼tumour-infiltrating lymphocytes;
NKCs¼natural killer cells; DCs¼dendritic cells. The underlined numbers¼significant.
Table 4 Correlation among immune cells
CD8
+TILs DCs
Variables Total (n¼45) Low/high P
a Low/high P
a
CD4
+TILs
Low 22 19/3 0.0011 17/5 0.0006
High 23 9/14 6/17
aw
2 test. TILs¼tumour-infiltrating lymphocytes; DCs¼dendritic cells.
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Figure 3 Kaplan–Meier analyses of the overall survival of gallbladder
cancer patients with either a low or high level of immune cell infiltration. P-
values were determined by the log-rank test. (A) CD4
þ TILs; (B) CD8
þ
TILs; (C) NKC infiltration; (D) DC infiltration.
Table 5 Univariate analyses with Cox’s proportional hazards model for
imuune cells and clinicopathological features in all 45 patients
Univariate
Variables Hazards ratio 95% CI
a P
b
CD4
+TILs 0.218 0.071–0.666 0.0075
CD8
+TILs 0.173 0.040–0.753 0.0194
NKCs 0.560 0.199–1.579 0.2727
DCs 0.358 0.128–1.006 0.0513
Age 0.215 0.076–0.609 0.0038
Sex 1.491 0.589–3.772 0.3990
pT 24.296 6.466–91.301 o0.0001
pN 9.651 3.499–26.619 o0.0001
G 5.419 1.989–14.760 0.0009
ly 5.518 2.022–15.060 0.0009
v 5.807 2.185–15.430 0.0004
ppn 4.733 1.831–12.237 0.0013
aCI¼confidence interval;
bfrom Cox regression test. TILs tumour-infiltrating
lymphocytes; NKCs¼natural killer cells; DCs¼dendritic cells. ly¼lymphatic
involvement; v¼vessel involvement; ppn¼perineural involvement.
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þ TILs, high CD8
þ
TILs, and high DC infiltration are each individual favourable
prognostic predictors.
Tumour-associated antigens (TAA) can be recognised by CD8
þ
T cells in the context of MHC class I-expressing tumours
(Schumacher et al, 2001). Overall immune responses, however,
were too weak and transient to eradicate cancer cells in the
majority of patients receiving immunisation (Wang, 2001).
Therefore, growing attention has been paid to the value of
CD4
þ T cells (Mumberg et al, 1999; Marzo et al, 2000; Beatty and
Paterson, 2001; Wang, 2001) and DCs (Lespagnard et al, 1999;
Almand et al, 2000) in antitumour immunity.
The correlation between DC infiltration and lymph-node
metastasis observed in the present study conforms to the theory
reported by Lespagnard et al (1999). Moreover, significant
correlations were observed between CD4
þ and CD8
þ T cells
and CD4
þ T cells and DCs. These results support the mechanism
of immune activation reported by Larsson et al (2001).
Compared with benign diseases, high levels of infiltrating CD4
þ
and CD8
þ T cells and DCs were observed in cancer specimens.
This outcome provides evidence that these immune cells possess
cancer-specific activities in gallbladder cancer.
As NKCs were frequently identified in cancer specimens and not
in benign diseases, NKC may have an ability to recognise cancer
cells. NKC infiltration, however, did not correlate with either
tumour progression or prognosis in this study. NKCs, constituting
only a small portion of the tumour-infiltrating lymphocytes
(Ishigami et al, 2000b), are components of the innate immune
system capable of lysing target cells without prior sensitization
(Cooper et al, 2001). Thus, the inability of NKCs to influence the
outcome of disease may depend on the low proportion of total cells
and weak anticancer specificity of NKCs.
We conclude as follows. Though the prognosis associated with
TILs is not always good, CD4
þ and CD8
þ TILs and intratumoural
DC infiltration, rather than NKCs, correlate with tumour progres-
sion, possibly serving as good prognostic predictors in patients
with adenocarcinoma of the gallbladder.
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